# Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study

> **NCT07191756** · — · ACTIVE_NOT_RECRUITING · sponsor: **Qiu Ye** · enrollment: 150 (estimated)

## Conditions studied

- Mucormycosis

## Interventions

- **DRUG:** Amphotericin B
- **DRUG:** Isavuconazole

## Key facts

- **NCT ID:** NCT07191756
- **Lead sponsor:** Qiu Ye
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2025-07-21
- **Final completion:** 2025-09-25
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07191756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07191756, "Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07191756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*